{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:44:05Z","timestamp":1789721045394,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Inhibitex"},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejmech.2013.09.047","type":"journal-article","created":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T21:35:16Z","timestamp":1381354516000},"page":"326-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides"],"prefix":"10.1016","volume":"70","author":[{"given":"Christopher","family":"McGuigan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bourdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Derudas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Hamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Hinsinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Kandil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Madela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Meneghesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Pertusati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Serpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Slusarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kolykhalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vernachio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Vanpouille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Introini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Balzarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2013.09.047_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1016370407633","article-title":"The potential of nucleoside analogs as inhibitors of retroviruses and tumors","author":"Robins","year":"1984","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2013.09.047_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"De Clercq","year":"2004","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.ejmech.2013.09.047_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/1098-1128(200011)20:6<417::AID-MED1>3.0.CO;2-Z","article-title":"Pronucleotides: toward the in\u00a0vivo delivery of antiviral and anticancer nucleotides","volume":"20","author":"Wagner","year":"2000","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2013.09.047_bib4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/AAC.41.5.1099","article-title":"Unique intracellular activation of the potent anti-human immunode\ufb01ciency virus agent 1592U89","volume":"41","author":"Faletto","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2013.09.047_bib5","first-page":"805","article-title":"In\u00a0vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver","volume":"25","author":"Rashidi","year":"1997","journal-title":"Drug Metab. Dispos"},{"key":"10.1016\/j.ejmech.2013.09.047_bib6","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.1073\/pnas.83.21.8333","article-title":"Phosphorylation of 3\u2032-azido-3\u2032-deoxythymidine and selective interaction of the 5\u2032-triphosphate with human immunodeficiency virus reverse transcriptase","volume":"83","author":"Furman","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2013.09.047_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1368-7646(02)00021-3","article-title":"Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms","volume":"5","author":"Gilbert","year":"2002","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2013.09.047_bib8","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1021\/jm701260b","article-title":"Prodrugs of phosphates and phosphonates","volume":"51","author":"Hecker","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.047_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/1389557043403936","article-title":"Aryloxy phosphoramidate trimesters as Pro-Tides","volume":"4","author":"Cahard","year":"2004","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.047_bib10","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/cmdc.200900289","article-title":"Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells","volume":"11","author":"Mehellou","year":"2009","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.047_bib11","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1016\/j.bmcl.2010.06.094","article-title":"Design, Synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus","volume":"20","author":"McGuigan","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.047_bib12","doi-asserted-by":"crossref","first-page":"8632","DOI":"10.1021\/jm2011673","article-title":"Phosphorodiamidates as a promising new phosphate prodrug motif for antiviral drug discovery: application to anti-HCV agents","volume":"54","author":"McGuigan","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.047_bib13","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1016\/j.ejmech.2011.05.040","article-title":"A\u00a0novel and efficient one-pot synthesis of symmetrical diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities","volume":"46","author":"Jansa","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.047_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/1389557043403945","article-title":"Designing a pronucleotide stratagem: lessons from amino acid phosphoramidates of anticancer and antiviral pyrimidines","volume":"4","author":"Drontle","year":"2004","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.047_bib15","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/jm100863x","article-title":"Discovery of a \u03b2-d-2\u2032-deoxy-2\u2032-\u03b1-fluoro-2\u2032-\u03b2-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus","volume":"53","author":"Sofia","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.047_bib16","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1246\/bcsj.42.3505","article-title":"Studies of phosphorylation. Iii. Selective phosphorylation of unprotected nucleosides","volume":"42","author":"Yoshikawa","year":"1969","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ejmech.2013.09.047_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/095632029100200106","article-title":"Synthesis and anti-HIV activity of some novel phosphorodiamidate derivatives of 3\u2032-azido-3\u2032-deoxythymidine (AZT)","volume":"2","author":"Jones","year":"1991","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ejmech.2013.09.047_bib18","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1021\/jm200815w","article-title":"Phosphoramidate ProTides of the anticancer agent FUDR successfully deliver the preformed bioactive monophosphate in cells and confer advantage over the parent nucleoside","volume":"54","author":"McGuigan","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.047_bib19","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/j.bmc.2005.02.041","article-title":"Anti-cancer ProTides: tuning the activity of BVDU phosphoramidates related to thymectacin","volume":"13","author":"McGuigan","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.047_bib20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chom.2008.07.008","article-title":"Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues","volume":"4","author":"Lisco","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2013.09.047_bib21","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1021\/jm0613370","article-title":"Application of the phosphoramidate ProTide approach to 4\u2032-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside","volume":"50","author":"Perrone","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.047_bib22","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1016\/j.bmcl.2009.05.099","article-title":"The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4\u2032-azidocytidine (R1479)","volume":"19","author":"McGuigan","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.047_bib23","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.bmc.2010.02.015","article-title":"Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin","volume":"18","author":"Derudas","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.047_bib24","unstructured":"M. Derudas, C. Vanpouille, A. Lisco, L. Margolis, J. Balzarini, C. McGuigan, Acyclic nucleoside ProTides: from antiherpetic to broad spectrum antiviral compounds, 241st ACS National Meeting, Anaheim, CA, USA, March 27th\u201331st 2011, MEDI-1."},{"key":"10.1016\/j.ejmech.2013.09.047_bib25","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1016\/j.bmcl.2010.10.035","article-title":"2\u2032-Deoxy-2\u2032-\u03b1-fluoro-2\u2032-\u03b2-C-methyl 3\u2032,5\u2032-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: discovery of PSI-352938","volume":"20","author":"Reddy","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.047_bib26","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1021\/jm9007856","article-title":"The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition","volume":"52","author":"Derudas","year":"2009","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413006284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413006284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T11:26:11Z","timestamp":1564485971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523413006284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":26,"alternative-id":["S0223523413006284"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.09.047","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.09.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}